Stock Market News & Stocks to Watch from StraightStocks » healthcare professionals

DrStockPick.com Stock Report! 10/29/09, CVAT, TGAL, HSP, ORCD, PLCE, PVA

Dr. Stock Pick — Thu, 29 Oct 2009 16:29:06 +0000

Dr Stock Pick HOT News & Alerts! _______________________________________ FREE Daily Stock Alerts From DrStockPick.com _______________________________________ Thursday October 29, 2009 DrStockPick.com Stock Report! ************************************************************** Cavitation Technologies, Inc. (OTC Bulletin Board: CVAT) is pleased to announce a 3-for-1 forward stock split effective at the market open Thursday, October 29th. CTI is a world leader in the development of technologies that represent [...]

Dell to Make Electronic Medical Records – Analyst Blog

Zacks Market Commentaries — Fri, 11 Sep 2009 21:00:58 +0000

Dell Inc. (DELL) recently said it would venture into the electronic medical records system business, which is used by doctors and hospitals. The device helps in storing medical records in a way that makes it easy to track the clinical history of patients from anywhere in the world without storing hard copies.

We believe the time is ideal for companies like Dell to enter this space as the federal government has granted around $19 billion in incentives to medical practitioners and hospitals. Electronic record-keeping software has huge prospects as most doctors currently use hard copies of medical records and the market is more or less recession proof.

Only 10% of American health care providers have adopted a full fledged electronic medical record system, so there is substantial growth potential in the segment. Dell is planning to combine its hardware with third-party software and provide services such as need assessment, system configuration, workflow process drawing and providing training and support to medical practitioners and hospitals.

Despite being a technical giant, Dell is likely to face stiff competition from bigger players like Google Inc. (GOOG) and Microsoft Corp. (MSFT). These companies have already launched personal health records storage systems to help patients store their own health data.

Thus, while this is a good business opportunity for Dell, it has to overcome many obstacles to be successful in the field. We believe healthcare professionals are increasingly adopting the concept of a paperless office and recognizing the benefits of cost efficient storage and greater accessibility of medical records.

Read the full analyst report on "DELL"
Read the full analyst report on "GOOG"
Read the full analyst report on "MSFT"
Zacks Investment Research

NEXC, ZYTC Stock-PR Pink Sheets Headlines September 10, 2009

Stock-PR — Thu, 10 Sep 2009 12:28:30 +0000

NexCen Brands, Inc. (PINK SHEETS: NEXC) announced today September 10, 2009 the signing of a master franchise agreement with Teixeira Development Group, an Angolan company, for the expansion of the Company’s Great American Cookies(R), MaggieMoo’s(R), Marble Slab Creamery(R), Pretzelmaker(R), TAF(TM), and Shoebox New York(R) brands. About NexCen Brands, Inc. NexCen Brands, Inc. is a strategic brand management [...]

Zargis Medical Corp. Begins Sale of Cardioscan Software, Addressing Cardiac Concerns

QualityStocks — Tue, 25 Aug 2009 19:15:51 +0000

Zargis Medical Corp., a spin-off from Siemens Corporate Research (NYSE:SI), a majority-owned subsidiary of Speedus Corp. (Nasdaq: SPDE), develops diagnostic decision support products and services for healthcare professionals. The company today announced that it has begun selling its Zargis Cardioscan heart sound analysis software, as well as 3M Health Care’s (NYSE: MMM) recently launched Bluetooth-enabled [...]

Eastman Kodak Co. (EK) Signs MMR Information Systems, Inc. (MMRF.OB) as Independent Software Vendor

QualityStocks — Fri, 21 Aug 2009 14:04:45 +0000

Kodak, the world’s foremost imaging innovator, today signed MyMedicalRecords, Inc. (“MMR”), a subsidiary of MMR Information Systems Inc., as their independent software vendor in an agreement that will enhance how doctors provide electronic information online. Kodak Scanners and Kodak Capture Software, both of which are state-of-the-art in their field, will work seamlessly with the MMR Pro [...]

Zacks Analyst Blog Highlights: Salesforce.com, Wal-Mart, Dell Inc., Google Inc. and Microsoft Corporation – Press Releases

Zacks Market Commentaries — Fri, 07 Aug 2009 13:30:15 +0000

For Immediate Release

Chicago, IL – August 7, 2009 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Salesforce.com (CRM), Wal-Mart (WMT), Dell Inc. (DELL), Google Inc. (GOOG) and Microsoft Corporation (MSFT).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513

Here are highlights from Thursday’s Analyst Blog:

CRM Focuses on Healthcare

The cloud computing model introduced by Salesforce.com, uses online software solutions created by it. We believe that the advantages of the model are particularly applicable to the company’s clientele. In addition to the user-friendly interface, cloud computing typically lowers IT staff requirements. So medical practitioners and other professionals who prefer to manage the system on their own will find it particularly useful.

Under the new agreement, Practice Fusion’s EMR (electronic medical records product line) will be combined with Salesforce.com’s cloud computing system to enhance value for customers. We think the deal comes at an opportune moment because the federal government passed a bill earlier this year, including around $30.0 billion in incentives to medical practitioners and hospitals for buying and using electronic record keeping software. We believe this is likely to generate additional business for companies such as Salesforce.com, as most doctors currently use hard copies of medical records.

Wal-Mart (WMT) is also trying to enter this segment, through collaboration with Dell Inc. (DELL). Other big companies such as Google Inc. (GOOG) and Microsoft Corporation (MSFT) have launched personal health records storage systems, which are helping patients to store their own health data. We believe electronic health records provide significant business opportunities, as healthcare professionals are increasingly adopting the concept of a paperless office and recognizing the benefits. We believe that growth in this segment is inevitable, as electronic records becoming accessible from anywhere and at any time makes life easy for both doctors and patients.

Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: http://at.zacks.com/?id=5515.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: http://at.zacks.com/?id=5517

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=5518.

Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

Contact:
Mark Vickery
Web Content Editor
312-265-9380
Visit: www.zacks.com

Zacks Investment Research

CRM Focuses on Healthcare – Analyst Blog

Zacks Market Commentaries — Thu, 06 Aug 2009 18:20:55 +0000

Healthcare provides a good business opportunity to information technology companies, a fact reinforced by Salesforce.com (CRM). The company is investing in Practice Fusion, which is involved in the business of electronic health records, health policy, health information technology and consumer medical data topics. Salesforce.com will invest around $10.0 million for a marginal stake in the company, which will generate around $1.0 million of revenue a year for the company.

The cloud computing model introduced by Salesforce.com, uses online software solutions created by it. We believe that the advantages of the model are particularly applicable to the company’s clientele. In addition to the user-friendly interface, cloud computing typically lowers IT staff requirements. So medical practitioners and other professionals who prefer to manage the system on their own will find it particularly useful.

Under the new agreement, Practice Fusion’s EMR (electronic medical records product line) will be combined with Salesforce.com’s cloud computing system to enhance value for customers. We think the deal comes at an opportune moment because the federal government passed a bill earlier this year, including around $30.0 billion in incentives to medical practitioners and hospitals for buying and using electronic record keeping software. We believe this is likely to generate additional business for companies such as Salesforce.com, as most doctors currently use hard copies of medical records.

Wal-Mart (WMT) is also trying to enter this segment, through collaboration with Dell Inc. (DELL). Other big companies such as Google Inc. (GOOG) and Microsoft Corporation (MSFT) have launched personal health records storage systems, which are helping patients to store their own health data. We believe electronic health records provide significant business opportunities, as healthcare professionals are increasingly adopting the concept of a paperless office and recognizing the benefits. We believe that growth in this segment is inevitable, as electronic records becoming accessible from anywhere and at any time makes life easy for both doctors and patients.
Read the full analyst report on "CRM"
Read the full analyst report on "WMT"
Read the full analyst report on "DELL"
Read the full analyst report on "GOOG"
Read the full analyst report on "MSFT"
Zacks Investment Research

PennyOmega.com Stock Report! 7/30/09, CYCC, MDRX, WEC, OMX, PTEN, HEP

PennyOmega.com — Thu, 30 Jul 2009 11:39:24 +0000

<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<

Arrayit Corporation (ARYC.OB) Announces 50 Percent Increase in Worldwide Product Sales

QualityStocks — Fri, 24 Jul 2009 02:59:20 +0000

Arrayit Corp., a proprietary life science company that has been the universal standard for printing and spotting microarrays since 1997, recently announced that the company’s worldwide product sales increased approximately 50 percent in the first half of 2009 to more than $3.1 million. Currently, more than 10,000 customers and 5,000 worldwide laboratories are utilizing the [...]

Cautious on Dendreon’s Rally – Analyst Blog

Zacks Market Commentaries — Mon, 06 Apr 2009 14:43:28 +0000

Shares of Dendreon Corp. (DNDN) jumped 38 percent last Friday and another 13% in early morning trading today. However, we don't see any clear rationale for the rally at this point of time. We believe investors are looking ahead to long-awaited data on the company's experimental Provenge vaccine to treat advanced prostate cancer, but we are cautious about the final results anticipated by the end of April.

As a reminder, Dendreon's lead drug candidate Provenge is under phase III IMPACT confirmatory study for prostate cancer under a special protocol assessment (SPA) with the FDA. Provenge is a therapeutic vaccine.

Previous two phase III studies generated mixed results. Study D9901 showed that Provenge approached, but did not meet its primary end point of showing a significant delay in time to disease progression (p=0.052, HR=1.4). However, Provenge showed a statistically significant median survival benefit (secondary endpoint) in patients with advanced prostate cancer (25.9 versus 21.5 months, p=0.01, HR=1.7) during the trial. Study D9902 did not achieve either the primary or secondary endpoint.

Despite the mixed results, DNDN submitted a biologics license application (BLA) for Provenge in November 2006 based on a combined analysis of the data from the D9901 and D9902A trials, which showed that patients on Provenge demonstrated a 23% improvement in median survival rate compared to patients on placebo (p=0.011, HR=1.8). In addition, the 36-month survival rate was 33% in patients who received Provenge compared to 15% in patients who received placebo.

To our surprise, the FDA Advisory Committee voted 17 to 0 in favor of the safety of Provenge in response to the question and 13 to 4 in favor of the efficacy question in March 2007. However, the FDA granted Provenge just an "approvable" opinion, requesting additional clinical data in support of the efficacy claim contained in the BLA.

Disappointed with the FDA decision, Dendreon initiated a third phase III trial D9902B (IMPACT) study. Late in May 2007, Dendreon confirmed that the FDA will accept either a positive interim or final analysis of survival data from its ongoing IMPACT study to amend the BLA for Provenge.

On October 6, 2008, the planned interim analysis of the phase III IMPACT clinical trial was conducted by the independent data monitoring committee (IDMC). The interim data did not achieve a statistical significance, but was very close to the 22% (20% actual) reduction in the risk of death based on 304 events.

Therefore, the company needs to depend on the final analysis to achieve statistical significance which is anticipated by the end of April. If the study demonstrates approximately a 22 percent reduction in the risk of death, based on 304 events, the company would expect the study to meet its primary endpoint of overall survival.

We are cautious about the final results of IMPACT since the study only enrolled about 500 patients. Investors may be encouraged by the news that the American Urological Association (AUA) on Friday invited Dendreon to de a late-breaker presentation for findings from IMPACT trial at its upcoming scientific meetings on April 28 in Chicago. Late-breaker presentations at medical meetings usually involve high-profile studies, or ones of particular interest to healthcare professionals.

However, selection of studies as a late breaker is no indication whether the data will be positive or negative. Dendreon will definitely release IMPACT data by the end of April, but may not do so at the meeting.

With the final IMPACT data only three weeks away, we certainly will keep a close eye on them, and will update investors as soon as the data are available.
Read the full analyst report on "DNDN"
Zacks Investment Research

iCAD Inc. (ICAD) is “One to Watch”

QualityStocks — Tue, 24 Feb 2009 18:52:36 +0000

Trading on the NASDAQ Capital Market, iCAD, Inc. is an industry-leading provider of Computer-Aided Detection (CAD) solutions. Headquartered in Nashua, New Hampshire, with additional offices in Beavercreek, Ohio, their solutions enable healthcare professionals to serve patients better by identifying pathologies and pinpointing cancer earlier. The Company’s solutions aid in the early detection of the most [...]

iCAD, Inc. (ICAD) Offers Tremendous Value to Investors

QualityStocks — Mon, 05 Jan 2009 16:51:23 +0000

iCAD, Inc. is an industry-leading provider of Computer-Aided Detection (CAD) solutions designed to enable healthcare professionals to better serve patients by identifying pathologies and pinpointing cancer earlier. The company provides a comprehensive array of high-performance, upgradeable CAD systems for the high, mid and low volume mammography markets. iCAD is currently trusted by more than a [...]

MedLink International Inc. (MLKNA.OB) is “One to Watch”

QualityStocks — Mon, 17 Nov 2008 22:16:44 +0000

Headquartered in Islandia, New York, and trading on the OTCBB, MedLink International Inc.’s commitment is to provide the medical community with applications and services that ease the accessibility of information related to patient care through the creation of a secure environment. MedLink International markets their line of IT products and services through their partnerships in [...]

Smith & Nephew plc (SNN) Expands ACTICOAT™ Line of Wound Dressings with Introduction of ACTICOAT™ Flex

QualityStocks — Fri, 07 Nov 2008 18:38:57 +0000

Most people that have scraped their fingers, hands, or face know from experience how difficult and discomforting it can be to keep these bendable and creased areas covered with a bandage. Smith & Nephew PLC, a top medical equipment and appliance supplier, said today it is introducing a new product to address this problem, [...]

VirtualHealth Technologies, Inc. (VHGI.OB) & Private Access, Inc. Debut ENVOII System Tray Notifier™ at Health 2.0 Conference

QualityStocks — Sat, 25 Oct 2008 13:11:55 +0000

The Envoii subsystem is licensed from Envoii Healthcare, L.L.C., a wholly-owned subsidiary of VirtualHealth Technologies, Inc. Private Access recently entered into a licensing agreement with Envoii to bundle the Envoii technology into their current software suite. The complete package, including the ENVOII System Tray Notifier(TM) technology, is being presented by Private Access during the Health [...]

Performance Health Technologies, Inc. (PFMH.OB) Keeps Patients’ Interest by Adding in Some Fun to Exercise

QualityStocks — Tue, 21 Oct 2008 17:28:15 +0000

Performance Health Technologies, Inc. (PFMH.OB) has put the element of fun into rehabilitation protocols. Rather than using traditional apparatus like weights and elastic bands to perform rehabilitation movements, Performance has developed a proprietary system that turns the rehabilitation into a wireless, game-like challenge. The Core:Tx® for Professionals has been designed to add an entertainment challenge [...]

Performance Health Technologies, Inc (PMFH.OB) is Serious About Rehabilitation

QualityStocks — Tue, 16 Sep 2008 12:12:16 +0000

There are a lot of people in our society who would rather work out alone versus in a gym surrounded by people. For some, it may be that they feel uncoordinated; unable to work the machines or do the aerobic moves. For others, it may be that they feel uncomfortable in their own skin. The [...]

VeriChip Corp. (CHIP): Locating and Tracking Potential for Investors

QualityStocks — Sat, 30 Aug 2008 14:28:16 +0000

VeriChip (CHIP) is a maker of radio frequency identification systems (RFID) used to identify, locate and track people across the United States and abroad. The company markets its products through direct sales force and distributors. Its customers include hospitals and long-term care facilities; healthcare professionals, such as physicians and individual patients. VeriChip’s main competitors are [...]

Exercise Credits: A Financial Incentive to Combat a Growing Health Epidemic

Mike Havrilla — Sun, 24 Aug 2008 13:14:00 +0000

Just as carbon credits were created out of the thin air to create a financial incentive to mitigate global warming through the reduction of greenhouse gas emissions; perhaps exercise credits should be considered as a new type of health commodity to combat the growing obesity epidemic in the United States and other [...]

Amedisys, Inc. (AMED) – A Leader in Home Health Services

QualityStocks — Thu, 14 Aug 2008 20:01:19 +0000

Amedisys is one of the leading providers of home healthcare in the United States and Puerto Rico. Headquartered in Baton Rouge, Louisiana, the company is dedicated to preserving a 26-year tradition of improving its patients’ quality of life. Amedisys employs the best, most highly-trained healthcare professionals who can accommodate the needs of virtually any patient. [...]

Cerner Should Vie for Visicu

Mike Havrilla — Sat, 28 Jul 2007 16:52:04 +0000

Visicu (EICU) continued its history of posting strong operating results, posting second quarter results on Thursday with in-line revenues of $9.1 million and beating the high estimate for net income by a penny at $0.06 per share or $2.1 million. Revenues increased 20% from the year-ago period while earnings per share levitated by a healthy [...]